Back to 
Sanders Capital, LLC
Sanders Capital, LLC
NVS
Showing 0 of 8 quarters
Position history for Sanders Capital, LLC's holdings in Novartis AG
No. Sanders Capital exited its NVS (Novartis) position in Q4 2023. Its Q3 2023 13F listed 1,073,420 shares worth $103.6M. Sanders Capital first reported NVS in Q1 2022 and held it in 7 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.